Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy
Phytotherapy Research · 2024-07 · 38 (7) · 3525-3551
DOI: 10.1002/ptr.8220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 03.05.2024. Verfasst von Aranka Brockmueller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany. Hauptthemen laut MEDLINE: Curcumin, Colorectal Neoplasms, Autophagy, Apoptosis. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) development and progression, one of the most common cancers globally, is supported by specific mechanisms to escape cell death despite chemotherapy, including cellular autophagy. Autophagy is an evolutionarily highly conserved degradation pathway involved in a variety of cellular processes, such as the maintenance of cellular homeostasis and clearance of foreign bodies, and its imbalance is associated with many diseases. However, the role of autophagy in CRC progression remains controversial, as it has a dual function, affecting either cell death or survival, and is associated with cellular senescence in tumor therapy. Indeed, numerous data have been presented that autophagy in cancers serves as an alternative to cell apoptosis when the latter is ineffective or in apoptosis‐resistant cells, which is why it is also referred to as programmed cell death type II. Curcumin, one of the active constituents of Curcuma longa , has great potential to combat CRC by influencing various cellular signaling pathways and epigenetic regulation in a safe and cost‐effective approach. This review discusses the efficacy of curcumin against CRC in vitro and in vivo, particularly its modulation of autophagy and apoptosis in various cellular pathways. While clinical studies have assessed the potential of curcumin in cancer prevention and treatment, none have specifically examined its role in autophagy. Nonetheless, we offer an overview of potential correlations to support the use of this polyphenol as a prophylactic or co‐therapeutic agent in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
- CARE Program, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain.
- Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B·ARGO), Barcelona, Spain.
- GRET and Toxicology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
ORCID-Profile: Aranka Brockmueller, Vicenç Ruiz de Porras, Mehdi Shakibaei
Zitieren
APA
Brockmueller, A., Ruiz de Porras, V., & Shakibaei, M. (2024). Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy. Phytotherapy Research, 38(7), 3525-3551. https://doi.org/10.1002/ptr.8220
Vancouver
Brockmueller A, Ruiz de Porras V, Shakibaei M. Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy. Phytotherapy Research. 2024;38(7):3525-3551. doi:10.1002/ptr.8220
BibTeX
@article{Brockmueller2024,
author = {Brockmueller, Aranka and Ruiz de Porras, Vicenç and Shakibaei, Mehdi},
title = {Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {7},
pages = {3525--3551},
doi = {10.1002/ptr.8220}
}
EUVIMED